Yamanaka K - Search Results

1

Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS.

Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan-Barmatz V, Cleveland DW. Israelson A, et al. Among authors: yamanaka k. Neuron. 2010 Aug 26;67(4):575-87. doi: 10.1016/j.neuron.2010.07.019. Neuron. 2010. PMID: 20797535 Free PMC article.

2

Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease.

Yamanaka K, Vande Velde C, Eymard-Pierre E, Bertini E, Boespflug-Tanguy O, Cleveland DW. Yamanaka K, et al. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):16041-6. doi: 10.1073/pnas.2635267100. Epub 2003 Dec 10. Proc Natl Acad Sci U S A. 2003. PMID: 14668431 Free PMC article.

3

Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.

Miller TM, Kaspar BK, Kops GJ, Yamanaka K, Christian LJ, Gage FH, Cleveland DW. Miller TM, et al. Among authors: yamanaka k. Ann Neurol. 2005 May;57(5):773-6. doi: 10.1002/ana.20453. Ann Neurol. 2005. PMID: 15852369 Free PMC article.

4

Determinants of rapid disease progression in ALS.

Yamanaka K, Cleveland DW. Yamanaka K, et al. Neurology. 2005 Dec 27;65(12):1859-60. doi: 10.1212/01.wnl.0000192717.25980.b5. Neurology. 2005. PMID: 16380607 No abstract available.

5

Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis.

Eymard-Pierre E, Yamanaka K, Haeussler M, Kress W, Gauthier-Barichard F, Combes P, Cleveland DW, Boespflug-Tanguy O. Eymard-Pierre E, et al. Among authors: yamanaka k. Ann Neurol. 2006 Jun;59(6):976-80. doi: 10.1002/ana.20879. Ann Neurol. 2006. PMID: 16718699

6

Onset and progression in inherited ALS determined by motor neurons and microglia.

Boillée S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. Boillée S, et al. Among authors: yamanaka k. Science. 2006 Jun 2;312(5778):1389-92. doi: 10.1126/science.1123511. Science. 2006. PMID: 16741123

7

Progressive spinal axonal degeneration and slowness in ALS2-deficient mice.

Yamanaka K, Miller TM, McAlonis-Downes M, Chun SJ, Cleveland DW. Yamanaka K, et al. Ann Neurol. 2006 Jul;60(1):95-104. doi: 10.1002/ana.20888. Ann Neurol. 2006. PMID: 16802286

8

Antisense oligonucleotide therapy for neurodegenerative disease.

Smith RA, Miller TM, Yamanaka K, Monia BP, Condon TP, Hung G, Lobsiger CS, Ward CM, McAlonis-Downes M, Wei H, Wancewicz EV, Bennett CF, Cleveland DW. Smith RA, et al. Among authors: yamanaka k. J Clin Invest. 2006 Aug;116(8):2290-6. doi: 10.1172/JCI25424. Epub 2006 Jul 27. J Clin Invest. 2006. PMID: 16878173 Free PMC article.

9

Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.

Miller TM, Kim SH, Yamanaka K, Hester M, Umapathi P, Arnson H, Rizo L, Mendell JR, Gage FH, Cleveland DW, Kaspar BK. Miller TM, et al. Among authors: yamanaka k. Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19546-51. doi: 10.1073/pnas.0609411103. Epub 2006 Dec 12. Proc Natl Acad Sci U S A. 2006. PMID: 17164329 Free PMC article.

10

Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis.

Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW. Yamanaka K, et al. Nat Neurosci. 2008 Mar;11(3):251-3. doi: 10.1038/nn2047. Epub 2008 Feb 3. Nat Neurosci. 2008. PMID: 18246065 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,729 results

Search Page

Filters